Our Pipeline

Prioritized therapeutic
areas of development.

Addressing life-threatening
and rare diseases

In addition to our first FDA-approved treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, we are working to extend our offerings to help even more people with life-threatening and rare diseases.

Rare Diseases

See Our Global Pipeline >